Vol. 6, Issue - 1, Part A (2022)

Each participant was well informed about the trial and written consent was obtained before initiation of the study. Demographic data and information on the present disease condition, concomitant disease and therapy was recorded. Thorough general physical and systemic clinical examination was carried out. Signs and Symptoms pertaining to gout were recorded in CRF. The vital parameters like blood pressure, heart rate, temperature and respiratory rate were also recorded. X-Ray of affected joints was conducted and blood samples were collected for the evaluation of laboratory parameters like Haemogram, C-Reactive proteins and serum uric acid to establish and confirm inclusion criteria and other laboratory test like complete blood picture, kidney function test, liver function test and routine and microscopic examination of urine were done. All clinical and laboratory follow-up were done at every 2 weeks.

The study was carried out in a total number of 96 patients of Waja-ul-Mafasil of either sex satisfying the criteria of American Rheumatism association. All the patients received treatment with Unani Pharmacopoeial formulations - Majoon-e-Sūranjān & Habb-e-Azaraqi a period of 60 days. Out of 96 cases 75 patients completed the study, 34 patients got complete remission, 36 patients got partially remission, 05 patients showed no relief and 21 patients dropped out. No hepatotoxic and nephrotoxic side effects noticed during the course of study. The clinical and laboratory findings after treatment have shown that both drugs possessed efficacy and safety in the treatment of niqris.